Roche returning rights to Inovio's HBV vaccine

By BC Staff | Aug 3, 2016 | 7:00 AM GMT

Inovio Pharmaceuticals Inc. (NASDAQ:INO) said Roche (SIX:ROG; OTCQX:RHHBY) is terminating a

Read the full 110 word article

How to gain access

Continue reading with a
two-week free trial.